Hub Group is undervalued with a positive future outlook not yet reflected in its share price, suggesting it's a good time to buy HUBG. Consideration of management track record and capital structure is also advised.
Hub Group's returns on capital remain steady, despite increased capital employed, indicating a lack of high return investments. If current trends persist, its chances of becoming a multi-bagger are slim.
Hub Group's robust EPS growth in recent years doesn't change the prediction that its future earnings growth may underperform market average. This is likely contributing to its P/E ratio staying below market levels. Without major improvements, its stock isn't forecasted to notably increase soon.
Hub Group's strong financials and profit utilization spell a positive outlook despite recent stock performance. Its hearty growth rate and reinvestment strategy could boost value, though future earnings growth may slow down.
Gainers: •$Clovis Oncology (CLVS.US)$+40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial) •$Dare Bioscience (DARE.US)$+13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO) •$KULR Technology (KULR.US)$+9.5% (secured a battery sa...
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Hub Group Stock Discussion
• $American Express (AXP.US)$ : Baird Upgrades to Outperform from Neutral - PT $175
• $The AZEK (AZEK.US)$ : BofA Securities Upgrades to Buy from Neutral
• $Capital One Financial (COF.US)$ : Baird Upgrades to Outperform from Neutral - PT $145
• $Fifth Third Bancorp (FITB.US)$ : Baird Upgrades to Outperform from Neutral - PT $44
• $M&T Bank (MTB.US)$ : Baird Upgrades to Outperform from Neutral - PT $200 (from $175)
• $NextEra Energy Partners LP (NEP.US)$ : RBC Cap...
• $GTY Technology (GTYH.US)$ +118.1% (entered into a definitive agreement to be acquired by GI Partners )
• $Finch Therapeutics (FNCH.US)$ +68.33% (announces removal of FDA clinical hold on CP101 IND)
• $Zymeworks (ZYME.US)$ +42.34% (confirms receipt of non-binding proposal from All Blue Falcons for $10.50 per share in cash)
• $Hub Group (HUBG.US)$ +16.3% (earnings reports)
• $Lantheus (LNTH.US)$ +14.2% (earnings reports)
• $Mohawk Industries (MHK.US)$ +13.7% (e...
• $Fortune Brands Home & Security (FBHS.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $84 (from $74)
• $Forward Air (FWRD.US)$ : Stifel Upgrades to Buy from Hold - PT $136 (from $122)
• $Grocery Outlet (GO.US)$ : BofA Securities Upgrades to Buy from Underperform - PT $37 (from $23)
• $Hub Group (HUBG.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $92 (from $76)
• $IQVIA Holdings (IQV.US)$ : Piper Sandler Upgrades to Overweight...
• $Baker Hughes (BKR.US)$ : HSBC Upgrades to Buy from Hold - PT $38.30
• $United Breweries Co Inc (CCU.US)$ : HSBC Upgrades to Buy from Hold - PT $17
• $Capital City Bank Group (CCBG.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $31.50 (from $29)
• $Hub Group (HUBG.US)$ : Susquehanna Upgrades to Positive from Neutral - PT $83 (from $92)
• $Interactive Brokers (IBKR.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $90
• $JB Hunt Transport Services (JBHT.US)$ : Susqueh...
• $Clovis Oncology (CLVS.US)$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience (DARE.US)$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology (KULR.US)$ +9.5% (secured a battery sa...
• $Baker Hughes (BKR.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $43
• $CDW Corp (CDW.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $214 (from $201)
• $Core & Main (CNM.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $34 (from $32)
• $Five Below (FIVE.US)$ : Citigroup Upgrades to Buy from Neutral - PT $205 (from $176)
• $Vector (VGR.US)$ : Barclays Uprages to Overweight from Equal Weight - PT $16 (from ...
No comment yet